Dr. Abud Bakri

Yeah, rectal enemas.

They did a phase one and phase two trial.

They're doing this daily or they do it once?

They did it for a few weeks and then they remeasured.

It was placebo controlled.

The data is not available.

The abstracts are only available.

So that's what also gives us some pause when we're going to push that forward, especially when the legal discussions are happening here in the next few months on PPC.

The phase one trial showed no adverse effects.

And they didn't even have BPC in the systemic system too.

That's a key point to know that orally administered or rectally administered BPC doesn't seem to go systemic.

Maybe define that a little bit more specifically.

If you take aspirin and then you measure blood aspirin levels, you'll notice the levels go up.

When they measured BPC levels, BPC-157 levels in these individuals, they didn't find it in the blood.

So either it was broken down very quickly or it stayed locally to the lining of the gastric tissues.

The bigger BPC protein?

Or intraperitoneal, like

They found fragments of the 15.

There's a paper in 2024 that looked at this, and they could figure out if somebody had BPC administered for doping reasons, because it's on the water list now.

So they could figure out if someone had taken BPC.